NCT06834802

Brief Summary

Statement of the problem: Soft tissue healing following immediate implant placement is one of the major factors that affect implant restoration, function \& success. Aim: The aim of this study is to compare the effect of using HAM (Human amniotic membrane) and platelet rich fibrin (PRF) in soft tissue healing with immediate implant placement in the molar region.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

February 19, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

February 14, 2025

Last Update Submit

February 14, 2025

Conditions

Keywords

jumping gapimmediate implant placemnetsoft tissue around implantsoft tissue healing

Outcome Measures

Primary Outcomes (1)

  • Soft tissue healing

    Surface area/intraoral scanner

    Baseline, every day for the first week, day after day second week, once in third and fourth week

Secondary Outcomes (1)

  • post operative pain

    Baseline, every day for the first week, day after day second week, once in third and fourth week

Study Arms (3)

Grafting with PRF

ACTIVE COMPARATOR

immediate implant will be placed and PRF membrane will be placed into the soft tissue. The PRF plug will be maintained in place with approximating sutures using 5-0 resorbable suture material.

Procedure: PRF

Grafting using Human amniotic membrane (HAM)

ACTIVE COMPARATOR

immediate implant placement will be done and The HAM plug will be placed into the soft tissue.

Procedure: Human amniotic membrane

No Grafting

ACTIVE COMPARATOR

Immediate implant placement will be done and with no soft tissue grafting

Procedure: No grafting

Interventions

PRFPROCEDURE

PRF membrane will be used for soft tissue grafting around implant

Grafting with PRF

Human amniotic membrane will be used for soft tissue grafting around implan

Grafting using Human amniotic membrane (HAM)
No graftingPROCEDURE

No soft tissue grafting around implant

No Grafting

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients at least 18 years old, with non-restorable first and second molars.
  • Minimum remaining alveolar height of four to six millimeters distance from the apex of the socket to the floor of maxillary sinus for maxillary teeth and minimum remaining alveolar height of six millimeters distance from the apex of the socket to the inferior alveolar nerve for mandibular teeth.
  • Minimum alveolar Bucco-palatal dimension of 7 mm.

You may not qualify if:

  • Patients with known systemic diseases which can affect normal bone formation or blood coagulation.
  • Patients who are smokers.
  • Presence of signs of active infection or pus formation.
  • Absence or loss of buccal wall prior to implant placement.
  • Bad oral hygiene

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of oral and dental medicine , Suez university

Cairo, Cairo Governorate, 123456, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Blinding of outcome assessors and participants will be achieved as the different outcomes will be assessed for all groups by assessors other than the researchers doing the procedures.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2025

First Posted

February 19, 2025

Study Start

January 7, 2025

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

February 19, 2025

Record last verified: 2025-01

Locations